Testing effectiveness (Phase 2)Ended earlyNCT01083641What this trial is testingEstrogen for Triple Negative Breast CancerWho this might be right forFemale Breast Cancer University of Wisconsin, Madison 17
Testing effectiveness (Phase 2)Study completedNCT00483223What this trial is testingPlatinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of ResponseWho this might be right forBreast Cancer Massachusetts General Hospital 86
Early research (Phase 1)Study completedNCT02316457What this trial is testingRNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uIDWho this might be right forBreast Cancer (Triple Negative Breast Cancer (TNBC)) BioNTech SE 42
Early research (Phase 1)Ended earlyNCT04254107What this trial is testingA Safety Study of SEA-TGT (SGN-TGT) in Advanced CancerWho this might be right forNon-small Cell Lung CancerGastric CarcinomaGastroesophageal Junction Carcinoma+9 more Seagen Inc. 133
Testing effectiveness (Phase 2)Study completedNCT02708680What this trial is testingRandomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead InWho this might be right forBreast Cancer Syndax Pharmaceuticals 89
Testing effectiveness (Phase 2)Active Not RecruitingNCT02393794What this trial is testingCisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)Who this might be right forTriple-Negative Breast CancerBreast Cancer Priyanka Sharma 51
Early research (Phase 1)Study completedNCT01837602What this trial is testingCMet CAR RNA T Cells Targeting Breast CancerWho this might be right forMetastatic Breast CancerTriple Negative Breast Cancer University of Pennsylvania 6
Testing effectiveness (Phase 2)Looking for participantsNCT06635980What this trial is testingHypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more Mayo Clinic 120
Testing effectiveness (Phase 2)UnknownNCT04739670What this trial is testingEvaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast CancerWho this might be right forMetastatic Triple Negative Breast Cancer Peter MacCallum Cancer Centre, Australia 31
Testing effectiveness (Phase 2)UnknownNCT06355037What this trial is testingDasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast CancerWho this might be right forTriple-negative Breast Cancer Fudan University 10
Not applicableNot Yet RecruitingNCT06418139What this trial is testingAssociation of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and ImmunotherapyWho this might be right forNon-Metastatic Breast Carcinoma Assistance Publique - Hôpitaux de Paris 450
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07552181What this trial is testingPhase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast CancerWho this might be right forTNBC - Triple-Negative Breast CancerTNBCEarly Stage Triple-Negative Breast Carcinoma Yuan Yuan 50
Testing effectiveness (Phase 2)Study completedNCT02130700What this trial is testingOral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast CancerWho this might be right forProstate Cancer Innocrin Pharmaceutical 17
Not applicableActive Not RecruitingNCT04030507What this trial is testingScreening Magnetic Resonance Imaging of the Brain in Patients With Breast CancerWho this might be right forBreast CancerHER2-positive Breast CancerTriple Negative Breast Cancer+3 more Brigham and Women's Hospital 214
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06229067What this trial is testingEfficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerWho this might be right forBreast CancerTriple Negative Breast Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 182
Very early researchNot Yet RecruitingNCT07671092What this trial is testingImaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLCWho this might be right forMetastatic Urothelial CarcinomaBreast CancerTNBC - Triple-Negative Breast Cancer+2 more RayzeBio, Inc. 40
Very early researchActive Not RecruitingNCT02744053What this trial is testingDCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast CancerWho this might be right forEstrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+1 more M.D. Anderson Cancer Center 96
Early research (Phase 1)Study completedNCT01920061What this trial is testingPF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)Who this might be right forNeoplasm Pfizer 110
Not applicableStudy completedNCT01395056What this trial is testingStudy of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsWho this might be right forBreast NeoplasmsNeoplasm Metastasis Peking University Cancer Hospital & Institute 23
Testing effectiveness (Phase 2)WithdrawnNCT07134556What this trial is testingPhase II Trial Evaluating the Safety and Efficacy of the Combination of Zimberelimab, Domvanalimab and Sacituzumab Govitecan as 1L Therapy for PD-L1 Positive Advanced TNBCWho this might be right forTriple Negative Breast CancerPDL-1 Positive MedSIR